Sigachi Industries
SIGACHI · NSEValuation
Blended fair value using DCF and peer comparison methods.
See if Sigachi Industries is undervalued
Unlock intrinsic value for 4,800+ Indian stocks — free.
Sign in or create free accountThe intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Healthcare · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
Sigachi Industries SIGACHI · you | ₹1,131 Cr | 43.5× | 2.5× | — | 5.8% | 0.1% | — |
| Sector median | — | 45.1× | 5.5× | 25.9× | 11.3% | 8.2% | 8.4% |
| Sanofi India Limited SANOFI | ₹7,249 Cr | 45.1× | 28.2× | 23.0× | 62.5% | 27.3% | — |
| Nephrocare Health Services Limited NEPHROPLUS | ₹6,944 Cr | 83.4× | 6.1× | 28.8× | 6.9% | 7.7% | 31.7% |
| Senores Pharmaceuticals Limited SENORES | ₹6,803 Cr | 365.6× | — | — | — | 0.0% | — |
| FDC Limited FDC | ₹5,781 Cr | 20.5× | 2.3× | 16.1× | 11.3% | 13.0% | 6.8% |
| Innova Captab Limited INNOVACAP | ₹5,064 Cr | 42.5× | 5.5× | 22.9× | 12.9% | 8.6% | 20.7% |
| IOL Chemicals and Pharmaceuticals Limited IOLCP | ₹4,853 Cr | 28.9× | 2.9× | — | 10.1% | 0.1% | — |
| Morepen Laboratories Limited MOREPENLAB | ₹4,776 Cr | 46.8× | 3.6× | 32.0× | 7.6% | 5.3% | 8.4% |
| Gujarat Themis Biosyn Limited GUJTHEM | ₹4,480 Cr | 81.1× | 13.2× | 61.4× | 16.2% | 28.2% | 3.6% |
Sigachi is fairly valued relative to sector peers — trading near the sector median on key multiples (P/E ~45.1×, EV/EBITDA ~25.9×). Focus on execution quality and earnings trajectory from here.
Business quality
Valuation
Returns
Growth
Efficiency
Liquidity & Solvency
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.